These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31012560)

  • 21. Efficacy and safety of clindamycin-tretinoin gel versus clindamycin or tretinoin alone in acne vulgaris: a randomized, double-blind, vehicle-controlled study.
    Jarratt MT; Brundage T
    J Drugs Dermatol; 2012 Mar; 11(3):318-26. PubMed ID: 22395582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of a fixed combination of clindamycin phosphate 1.2%-benzoyl peroxide 2.5% aqueous gel on health-related quality of life in moderate to severe acne vulgaris.
    Webster G; Thiboutot DM; Chen DM; Merikle E
    Cutis; 2010 Nov; 86(5):263-7. PubMed ID: 21214129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination of azelaic acid 5% and clindamycin 2% for the treatment of acne vulgaris.
    Pazoki-Toroudi H; Nilforoushzadeh MA; Ajami M; Jaffary F; Aboutaleb N; Nassiri-Kashani M; Firooz A
    Cutan Ocul Toxicol; 2011 Dec; 30(4):286-91. PubMed ID: 21612319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 3.75% for the once-daily treatment of moderate to severe acne vulgaris.
    Pariser DM; Rich P; Cook-Bolden FE; Korotzer A
    J Drugs Dermatol; 2014 Sep; 13(9):1083-9. PubMed ID: 25226009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized, double-blind, placebo-controlled, pilot study to assess the efficacy and safety of clindamycin 1.2% and tretinoin 0.025% combination gel for the treatment of acne rosacea over 12 weeks.
    Chang AL; Alora-Palli M; Lima XT; Chang TC; Cheng C; Chung CM; Amir O; Kimball AB
    J Drugs Dermatol; 2012 Mar; 11(3):333-9. PubMed ID: 22395584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clindamycin phosphate 1.2%/benzoyl peroxide 3% fixed-dose combination gel versus topical combination therapy of adapalene 0.1% gel and clindamycin phosphate 1.2% gel in the treatment of acne vulgaris in Japanese patients: A multicenter, randomized, investigator-blind, parallel-group study.
    Hayashi N; Kurokawa I; Siakpere O; Endo A; Hatanaka T; Yamada M; Kawashima M
    J Dermatol; 2018 Aug; 45(8):951-962. PubMed ID: 29905384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clindamycin phosphate 1.2%- tretinoin 0.025% gel: vehicle characteristics, stability, and tolerability.
    Del Rosso JQ; Jitpraphai W; Bhambri S; Momin S
    Cutis; 2008 May; 81(5):405-8. PubMed ID: 18543590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and Safety of Tazarotene 0.1% Plus Clindamycin 1% Gel Versus Adapalene 0.1% Plus Clindamycin 1% Gel in Facial Acne Vulgaris: A Randomized, Controlled Clinical Trial.
    Maiti R; Sirka CS; Ashique Rahman MA; Srinivasan A; Parida S; Hota D
    Clin Drug Investig; 2017 Nov; 37(11):1083-1091. PubMed ID: 28913735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fixed Combination of Clindamycin Phosphate 1.2% and Benzoyl Peroxide 3.75% Aqueous Gel: Long-Term Use in Adult Females With Moderate Acne Vulgaris.
    Kircik LH
    J Drugs Dermatol; 2017 Jun; 16(6):543-546. PubMed ID: 28686771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clindamycin phosphate-tretinoin combination gel revisited: status report on a specific formulation used for acne treatment.
    Del Rosso JQ
    Cutis; 2017 Mar; 99(3):179-183. PubMed ID: 28398420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Erythema-directed digital photography for the enhanced evaluation of topical treatments for acne vulgaris.
    Micali G; Dall'Oglio F; Tedeschi A; Lacarrubba F
    Skin Res Technol; 2018 Aug; 24(3):440-444. PubMed ID: 29383779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conjoint analysis: a novel, rigorous tool for determining patient preferences for topical antibiotic treatment for acne. A randomised controlled trial.
    Kellett N; West F; Finlay AY
    Br J Dermatol; 2006 Mar; 154(3):524-32. PubMed ID: 16445786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of tretinoin 0.025%/clindamycin phosphate 1.2% gel in combination with benzoyl peroxide 6% cleansing cloths for the treatment of facial acne vulgaris.
    Zeichner JA; Wong V; Linkner RV; Haddican M
    J Drugs Dermatol; 2013 Mar; 12(3):277-82. PubMed ID: 23545909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel Tretinoin 0.05% Lotion for Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in a Hispanic Population.
    Cook-Bolden FE; Weinkle SH; Guenin E; Bhatt V
    J Drugs Dermatol; 2019 Jan; 18(1):32-38. PubMed ID: 30681791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fitzpatrick skin types and clindamycin phosphate 1.2%/benzoyl peroxide gel: efficacy and tolerability of treatment in moderate to severe acne.
    Callender VD
    J Drugs Dermatol; 2012 May; 11(5):643-8. PubMed ID: 22527435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical efficacy of Velac, a new tretinoin and clindamycin phosphate gel in acne vulgaris.
    Cambazard F
    J Eur Acad Dermatol Venereol; 1998 Sep; 11 Suppl 1():S20-7; discussion S28-9. PubMed ID: 9891905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of benzoyl peroxide 5% clindamycin combination gel versus adapalene 0.1% on quality of life in patients with mild to moderate acne vulgaris: a randomized single-blind study.
    Guerra-Tapia A
    J Drugs Dermatol; 2012 Jun; 11(6):714-22. PubMed ID: 22648218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel Tretinoin 0.05% Lotion for the Once-daily Treatment of Moderate-to-Severe Acne Vulgaris in an Adult and Adolescent Female Population.
    Kircik LH; Baldwin H; Lain E; Guenin E; Harris S; Bhatt V
    J Drugs Dermatol; 2019 Feb; 18(2):178-188. PubMed ID: 30811141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and tolerability of a fixed combination of clindamycin phosphate (1.2%) and low concentration benzoyl peroxide (2.5%) aqueous gel in moderate or severe acne subpopulations.
    Webster G; Rich P; Gold MH; Mraz S; Calvarese B; Chen D
    J Drugs Dermatol; 2009 Aug; 8(8):736-43. PubMed ID: 19663111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of moderate to severe acne vulgaris in a Hispanic population: a post-hoc analysis of efficacy and tolerability of clindamycin phosphate 1.2%/benzoyl peroxide 2.5% gel.
    Cook-Bolden FE
    J Drugs Dermatol; 2012 Apr; 11(4):455-9. PubMed ID: 22453581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.